Portfolio Rapha Capital Management

Rapha Capital Management Participates in Series D Financing for Poseida Therapeutics

By Kevin SlawinJune 25, 2020February 4th, 2021No Comments

Poseida Therapeutics and Rapha Capital Management
Rapha Capital Management Participates in Series D Financing for Poseida Therapeutics
June 25, 2020

Previous PostPreliminary Results from NexImmune’s Phase 1/2 Trial of NEXI-001 in AML Presented at 62nd ASH Annual Meeting and Exposition
Next PostBetter than Eylea, as durable as gene therapy? Perceptive, Xontogeny boost ophthalmic startup's shot for best of all worlds

© 2024 Ponce Therapeutics. Privacy Policy | Terms & Conditions